In this work, by using publicly available databases containing gene expression data and clinical information obtained from cancer patients, we identified two SE-associated genes – NSMCE2 and MAL2 – that are enriched in breast tumors when compared to non-cancerous tissue and that are linked to breast cancer patients’ poor prognosis. This evidence concerns the gene MAL2 and breast cancer.